Bayer Q3 earnings beat expectations on pharma

Bayer, the German drugmaker that is buying U.S. seed company Monsanto, beat expectations for third-quarter earnings on gains in pharmaceuticals and forecast-beating farming pesticides.Reuters | October 26, 2016, 12:46 IST

Bayer, the inventor of aspirin and maker of Yasmin birth control pills, now aims to increase full-year core earnings per share from continuing operations by a high-single-digit percentage, compared with a previous goal of a mid- to high-single-digit percentage gain.

With immense pride “India Live” celebrated its 10th national conference in Mumbai from 28th February to 3rd March 2019. The conference turned out to be a gold mine of information, with emphasis on academics, education and exchange of knowledge with leaders in interventional cardiology from both India and abroad.